Sagimet Biosciences Inc (SGMT)’s financial ratios: A comprehensive overview

The closing price of Sagimet Biosciences Inc (NASDAQ: SGMT) was $5.73 for the day, up 9.56% from the previous closing price of $5.23. In other words, the price has increased by $+0.50 from its previous closing price. On the day, 1259420 shares were traded. SGMT stock price reached its highest trading level at $6.06 during the session, while it also had its lowest trading level at $5.00.

Ratios:

Our analysis of SGMT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.04 and its Current Ratio is at 17.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.

On August 08, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $67.Piper Sandler initiated its Overweight rating on August 08, 2023, with a $67 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 07 ’23 when Happel David bought 1,600 shares for $4.10 per share. The transaction valued at 6,560 led to the insider holds 627,100 shares of the business.

Happel David bought 590 shares of SGMT for $1,386 on Nov 16 ’23. The President & CEO now owns 590 shares after completing the transaction at $2.35 per share. On Jul 18 ’23, another insider, SEIDENBERG BETH C, who serves as the Director of the company, bought 46,875 shares for $16.00 each. As a result, the insider paid 750,000 and bolstered with 46,875 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 182.76M and an Enterprise Value of 81.02M. For the stock, the TTM Price-to-Sale (P/S) ratio is 65.61 while its Price-to-Book (P/B) ratio in mrq is 1.44. Its current Enterprise Value per Revenue stands at 40.51 whereas that against EBITDA is -2.83.

Stock Price History:

Over the past 52 weeks, SGMT has reached a high of $20.71, while it has fallen to a 52-week low of $2.13. The 50-Day Moving Average of the stock is 7.50, while the 200-Day Moving Average is calculated to be 8.17.

Shares Statistics:

SGMT traded an average of 1.70M shares per day over the past three months and 1.53M shares per day over the past ten days. A total of 21.38M shares are outstanding, with a floating share count of 12.12M. Insiders hold about 47.04% of the company’s shares, while institutions hold 53.10% stake in the company. Shares short for SGMT as of Feb 29, 2024 were 1.62M with a Short Ratio of 1.05, compared to 1.08M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.06% and a Short% of Float of 6.52%.

Earnings Estimates

The firm’s stock currently is rated by 5 analysts. The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.29 and low estimates of -$0.6.

Analysts are recommending an EPS of between -$1.53 and -$2.62 for the fiscal current year, implying an average EPS of -$2.07. EPS for the following year is -$3.64, with 5 analysts recommending between -$2.62 and -$4.53.

Most Popular